NASDAQBMRN
Year
View
| Form | Description | Date | Format |
|---|---|---|---|
| SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | Feb 14, 2002 |    |
Search
Search
Innovative therapeutics
 |
DiseasesLysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS |
Products
Palynziq™ |
Patient/Physician Support Contact InformationBioMarin RareConnections™ Global Medical Information |